MACROGENICS INC. - COMMON STOCK
3,2300
24-января-25 16:45:00
15 мин. задержка
Акции
+0,0700
+2,22%
Сегодняшний диапазон
3,0750 - 3,3650
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call
31 июл 2023 17:35:00 Источник Nasdaq GlobeNewswire
-
MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial Results
09 май 2023 16:01:45 Источник Nasdaq GlobeNewswire
-
MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call
04 май 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
MacroGenics to Participate in Upcoming Investor Conferences
24 апр 2023 18:15:00 Источник Nasdaq GlobeNewswire
-
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)
22 мар 2023 13:22:37 Источник Nasdaq GlobeNewswire
-
MacroGenics Provides Corporate Update and 2022 Financial Results
15 мар 2023 16:01:35 Источник Nasdaq GlobeNewswire
-
MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million
08 мар 2023 17:36:43 Источник Nasdaq GlobeNewswire
-
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call
07 мар 2023 18:00:00 Источник Nasdaq GlobeNewswire
-
MacroGenics to Participate in Upcoming Investor Conferences
02 мар 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
MacroGenics to Participate in Upcoming Investor Conferences
06 фев 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 янв 2023 17:50:00 Источник Nasdaq GlobeNewswire
-
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
04 янв 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
17 ноя 2022 18:10:00 Источник Nasdaq GlobeNewswire
-
MacroGenics Provides Corporate Update and Third Quarter 2022 Financial Results
03 ноя 2022 16:01:01 Источник Nasdaq GlobeNewswire
-
MacroGenics to Participate in Upcoming Investor Conferences
02 ноя 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call
26 окт 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
MacroGenics to Participate in Upcoming Investor Conferences
02 сен 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
MacroGenics Provides Update on Corporate Progress and Second Quarter 2022 Financial Results
08 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
MacroGenics Announces Date of Second Quarter 2022 Financial Results Conference Call
25 июл 2022 16:01:00 Источник Nasdaq GlobeNewswire